72.6 F
New York
Monday, May 17, 2021

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

OpGen, Inc. [NASDAQ: OPGN] revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of this deal is to develop a modern solution to identify, trace, and control antimicrobial-resistant infections at healthcare institutions statewide.

This deal is being continued ahead of the second-year development phase by another six months through September 30, 2021. OpGen has successfully attained all the discoveries of the first and second-year phases for the expansion of infectious disease digital health.

Now, OPGN is endeavoring to collaborate with Wadsworth Center of DOH and the participating healthcare systems. The main aim of the firm is to increase the reach of the platform, boost the volume of testing, and optimize data collection. 

The ongoing pandemic has caused a reduction in testing throughout 2020. So, the expansion and extension phase enables all stakeholders to create more data as testing volumes have been growing considerably from the fall of 2020 month by month until the close of March 2021 to date.

Furthermore, OpGen, DOH along all the stakeholders will continue to work collaboratively to illustrate that sustainable, flexible infectious diseases reporting, tracing, and monitoring tools for antimicrobial protection can be applied across New York State.

The firm disclosed that it is a great breakthrough for the firm as the department has decided to continue collaborating with it. Shares of the firm soared 0.44% at $2.2900 during the pre-market trading session of Monday.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...